Sun Pharma.Inds.

{
  "main_header": {
    "sid": 948699,
    "name": "Sun Pharma.Inds.",
    "stock_name": "Sun Pharma.Inds.",
    "full_name": "Sun Pharmaceutical Industries Ltd",
    "name_url": "stocks-analysis/sun-pharmainds",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,728.45",
    "chg": -28.9,
    "chgp": "-1.64%",
    "dir": -1,
    "prev_price": "1,757.35",
    "mcapval": "421,647.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 524715,
    "symbol": "SUNPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE044A01036",
    "curr_date": "Apr 01",
    "curr_time": "",
    "bse_nse_vol": "36.9 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 01, 2026",
    "traded_date_str": "2026 04 01",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "P/E at 34.72 vs Industry's 31.39: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-nifty-50-membership-reinforces-market-standing-amid-institutional-shifts-3927724",
        "imagepath": "",
        "date": "2026-04-01 09:26:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Amidst Sector Norms</strong></p>\n                <p>The stock’s P/E ratio of 34.72 stands approximately 10.6% above the industry average of 31.39, signalling a valuation premium that investors are currently willing to pay for <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a>. This premium suggests expectations of relatively stronger earnings growth or superior business fundamentals compared to peers. However, the premium is not excessively stretched, indicating a balanced market view rather than exuberance. The sector’s P/E itself reflects the pharmaceutical industry’s growth prospects and risk profile, with the company’s valuation aligning with its large-cap status and m..."
      },
      {
        "title": "P/E at 35.45 vs Industry's 31.90: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-and-institutional-dynamics-3923598",
        "imagepath": "",
        "date": "2026-03-30 09:26:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Reflecting Market Confidence?</strong></p>\n                <p>The current P/E ratio of <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> at 35.45 stands noticeably above the sector average of 31.90. This premium suggests that investors are willing to pay more for each rupee of earnings compared to the broader Pharmaceuticals &amp; Biotechnology industry. Such a valuation gap often implies expectations of superior earnings growth or a perception of stronger fundamentals relative to peers. However, it also raises questions about whether the premium is justified given the company’s recent performance trends — <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.in..."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sun-pharmaceutical-industries-ltd-is-rated-buy-3922751",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_mojoScore_3922751.png",
        "date": "2026-03-29 10:10:26",
        "description": "Sun Pharmaceutical Industries Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Sun Pharmaceutical Gains 1.02%: 5 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-gains-102-5-key-factors-driving-the-weeks-momentum-3921809",
        "imagepath": "",
        "date": "2026-03-28 13:05:12",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Mar:</strong> Stock declined 1.19% amid broad market sell-off</p>\n                    <p><strong>24 Mar:</strong> Significant open interest surge despite slight price dip</p>\n                    <p><strong>25 Mar:</strong> Intraday high reached with 3.08% surge and strong derivatives activity</p>\n                    <p><strong>27 Mar:</strong> Call option activity peaks ahead of expiry; price closes near 52-week high</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,777.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">..."
      },
      {
        "title": "Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-significant-open-interest-surge-amid-bullish-market-positioning-3920100",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_oi_spurts_by_underlying_3920100.png",
        "date": "2026-03-27 15:00:53",
        "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with rising volumes and improved technical indicators, suggests growing investor confidence in the pharmaceutical giant’s near-term prospects."
      },
      {
        "title": "14,049 Call Contracts Traded on Sun Pharmaceutical Industries Ltd as Stock Nears Rs 1,820 Strike",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-surge-in-call-option-activity-ahead-of-expiry-3919396",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_most_active_stocks_calls_3919396.png",
        "date": "2026-03-27 12:00:05",
        "description": "On 27 Mar 2026, 14,049 call contracts at the Rs 1,820 strike price changed hands on Sun Pharmaceutical Industries Ltd, with the stock closing at Rs 1,806. This near at-the-money activity coincides with a two-day rally that has lifted the stock 3.07%, signalling a synchronised directional stance in both the cash and derivatives markets."
      },
      {
        "title": "P/E at 35.63 vs Industry's 32.13: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-as-a-key-nifty-50-constituent-amid-institutional-confidence-3918629",
        "imagepath": "",
        "date": "2026-03-27 09:21:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Reflecting Sector Confidence</strong></p>\n                <p>The current P/E of <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> stands at 35.63, exceeding the Pharmaceuticals &amp; Biotechnology sector average of 32.13. This premium suggests that investors are willing to pay more for the stock relative to its peers, potentially reflecting expectations of superior earnings growth or stability. However, the premium is moderate rather than extreme, indicating a balanced valuation environment. The market capitalisation of Rs 4,32,600 crores further cements its status as a large-cap stalwart within the sector.</p>\n                <p>Such a valuation premium often invites scr..."
      },
      {
        "title": "Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-significant-open-interest-surge-amid-bullish-momentum-3916520",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_oi_spurts_by_underlying_3916520.png",
        "date": "2026-03-25 15:00:57",
        "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. This development comes alongside a strong price performance, with the stock nearing its 52-week high and outperforming its sector peers, reflecting renewed investor confidence in the large-cap pharmaceutical giant."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Surges 3.08% to Day's High of Rs 1805.9 — Outperforms Sector by 0.63 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-hits-intraday-high-with-strong-308-surge-3916430",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_priceRelatedfactors_3916430.png",
        "date": "2026-03-25 14:16:30",
        "description": "The Sensex climbed 1.98% on 25 Mar 2026, yet Sun Pharmaceutical Industries Ltd outpaced the broader market with a 3.08% gain, reaching an intraday high of Rs 1805.9. This 0.63 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector’s 2.49% advance signals a stock-specific strength rather than a mere market tailwind."
      }
    ],
    "total": 1033,
    "sid": "948699",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699"
  },
  "announcements": [
    {
      "caption": "Updates On Fibromun And Nidlegy",
      "datetime": "28-Mar-2026",
      "details": "Updates on Fibromun and Nidlegy",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "27-Mar-2026",
      "details": "Press Release",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "Intimation for Trading window closure",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>1100%</strong> dividend, ex-date: 05 Feb 26",
          "dt": "2026-02-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10",
          "dt": "2010-11-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13",
          "dt": "2013-07-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

P/E at 34.72 vs Industry's 31.39: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-04-01 09:26:04

Valuation Picture: Premium Amidst Sector Norms

The stock’s P/E ratio of 34.72 stands approximately 10.6% above the industry average of 31.39, signalling a valuation premium that investors are currently willing to pay for Sun Pharmaceutical Industries Ltd. This premium suggests expectations of relatively stronger earnings growth or superior business fundamentals compared to peers. However, the premium is not excessively stretched, indicating a balanced market view rather than exuberance. The sector’s P/E itself reflects the pharmaceutical industry’s growth prospects and risk profile, with the company’s valuation aligning with its large-cap status and m...

Read full news article

P/E at 35.45 vs Industry's 31.90: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-03-30 09:26:00

Valuation Picture: Premium Reflecting Market Confidence?

The current P/E ratio of Sun Pharmaceutical Industries Ltd at 35.45 stands noticeably above the sector average of 31.90. This premium suggests that investors are willing to pay more for each rupee of earnings compared to the broader Pharmaceuticals & Biotechnology industry. Such a valuation gap often implies expectations of superior earnings growth or a perception of stronger fundamentals relative to peers. However, it also raises questions about whether the premium is justified given the company’s recent performance trends — Read full news article

Sun Pharmaceutical Industries Ltd is Rated Buy

2026-03-29 10:10:26

Sun Pharmaceutical Industries Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Sun Pharmaceutical Gains 1.02%: 5 Key Factors Driving the Week’s Momentum

2026-03-28 13:05:12

Key Events This Week

23 Mar: Stock declined 1.19% amid broad market sell-off

24 Mar: Significant open interest surge despite slight price dip

25 Mar: Intraday high reached with 3.08% surge and strong derivatives activity

27 Mar: Call option activity peaks ahead of expiry; price closes near 52-week high

Week Open

Rs.1,777.45

...

Read full news article

Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Market Positioning

2026-03-27 15:00:53

Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with rising volumes and improved technical indicators, suggests growing investor confidence in the pharmaceutical giant’s near-term prospects.

Read full news article

14,049 Call Contracts Traded on Sun Pharmaceutical Industries Ltd as Stock Nears Rs 1,820 Strike

2026-03-27 12:00:05

On 27 Mar 2026, 14,049 call contracts at the Rs 1,820 strike price changed hands on Sun Pharmaceutical Industries Ltd, with the stock closing at Rs 1,806. This near at-the-money activity coincides with a two-day rally that has lifted the stock 3.07%, signalling a synchronised directional stance in both the cash and derivatives markets.

Read full news article

P/E at 35.63 vs Industry's 32.13: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-03-27 09:21:03

Valuation Picture: Premium Reflecting Sector Confidence

The current P/E of Sun Pharmaceutical Industries Ltd stands at 35.63, exceeding the Pharmaceuticals & Biotechnology sector average of 32.13. This premium suggests that investors are willing to pay more for the stock relative to its peers, potentially reflecting expectations of superior earnings growth or stability. However, the premium is moderate rather than extreme, indicating a balanced valuation environment. The market capitalisation of Rs 4,32,600 crores further cements its status as a large-cap stalwart within the sector.

Such a valuation premium often invites scr...

Read full news article

Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Momentum

2026-03-25 15:00:57

Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. This development comes alongside a strong price performance, with the stock nearing its 52-week high and outperforming its sector peers, reflecting renewed investor confidence in the large-cap pharmaceutical giant.

Read full news article

Sun Pharmaceutical Industries Ltd Surges 3.08% to Day's High of Rs 1805.9 — Outperforms Sector by 0.63 Percentage Points

2026-03-25 14:16:30

The Sensex climbed 1.98% on 25 Mar 2026, yet Sun Pharmaceutical Industries Ltd outpaced the broader market with a 3.08% gain, reaching an intraday high of Rs 1805.9. This 0.63 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector’s 2.49% advance signals a stock-specific strength rather than a mere market tailwind.

Read full news article

View All News